Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 551

1.

Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function.

Gunther JR, Park C, Dabaja BS, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, Garg N, Amini B, Steiner R, Nair R, Strati P, Westin JR, Ju Lee H, Fowler N, Nastoupil L, Neelapu SS, Pinnix CC.

Leuk Lymphoma. 2019 Aug 2:1-5. doi: 10.1080/10428194.2019.1644333. [Epub ahead of print] No abstract available.

PMID:
31373240
2.

Additional therapy improves outcomes in completely resected, limited-stage follicular lymphoma.

Andraos TY, Ayoub Z, Nastoupil LJ, Milgrom SA, Pinnix CC, Ng SP, Gunther JR, Fowler NH, Neelapu SS, Samaniego F, Fayad LE, Dabaja BS.

Leuk Lymphoma. 2019 Jun 24:1-8. doi: 10.1080/10428194.2019.1627535. [Epub ahead of print]

PMID:
31234671
3.

Impact of perioperative pain management protocol on opioid prescribing patterns.

Thuener JE, Clancy K, Scher M, Ascha M, Harrill K, Ahadizadeh E, Rezaee R, Fowler N, Lavertu P, Teknos T, Zender C.

Laryngoscope. 2019 Jun 12. doi: 10.1002/lary.28133. [Epub ahead of print]

PMID:
31188488
4.

Preserving the branch to the vastus intermedius increases anterolateral thigh flap versatility.

Kurlander DE, Melki S, Joshi R, Thuener J, Li S, Fowler N, Zender C, Rezaee R.

Laryngoscope. 2019 May 31. doi: 10.1002/lary.28093. [Epub ahead of print] No abstract available.

PMID:
31150118
5.

Ibrutinib and Venetoclax for First-Line Treatment of CLL.

Jain N, Keating M, Thompson P, Ferrajoli A, Burger J, Borthakur G, Takahashi K, Estrov Z, Fowler N, Kadia T, Konopleva M, Alvarado Y, Yilmaz M, DiNardo C, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Sasaki K, Kanagal-Shamanna R, Patel K, Jorgensen J, Garg N, Wang X, Sondermann K, Cruz N, Wei C, Ayala A, Plunkett W, Kantarjian H, Gandhi V, Wierda W.

N Engl J Med. 2019 May 30;380(22):2095-2103. doi: 10.1056/NEJMoa1900574.

PMID:
31141631
6.

A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas.

Strati P, Nastoupil LJ, Davis RE, Fayad LE, Fowler N, Hagemeister FB, Kwak L, Oki Y, Wang M, Westin J, Ruben CE, Wesson ET, Piekarz R, Fanale MA, Lee HJ.

Haematologica. 2019 May 9. pii: haematol.2019.220012. doi: 10.3324/haematol.2019.220012. [Epub ahead of print]

7.

Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma.

Pinnix CC, Milgrom SA, Cheah CY, Gunther JR, Ludmir EB, Wogan CF, Nastoupil LJ, Neelapu SS, Westin J, Lee HJ, Iyer SP, Steiner RE, Fayad LE, Fowler NH, Wang ML, Samaniego F, Rodriguez MA, Rich AE, Medeiros LJ, Dabaja BS.

Blood Adv. 2019 May 14;3(9):1356-1367. doi: 10.1182/bloodadvances.2018029140.

8.

American marten and fisher do not segregate in space and time during winter in a mixed-forest system.

Croose E, Bled F, Fowler NL, Beyer DE Jr, Belant JL.

Ecol Evol. 2019 Apr 1;9(8):4906-4916. doi: 10.1002/ece3.5097. eCollection 2019 Apr.

9.

Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma.

Barta SK, Zain J, MacFarlane AW 4th, Smith SM, Ruan J, Fung HC, Tan CR, Yang Y, Alpaugh RK, Dulaimi E, Ross EA, Campbell KS, Khan N, Siddharta R, Fowler NH, Fisher RI, Oki Y.

Clin Lymphoma Myeloma Leuk. 2019 Jun;19(6):356-364.e3. doi: 10.1016/j.clml.2019.03.022. Epub 2019 Apr 3.

PMID:
31029646
10.

Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.

Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Yehia Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, Lee HJ, Oki Y, Wang M, Samaniego F, Chi L, Esmaeli B.

Head Neck. 2019 May;41(5):1546. doi: 10.1002/hed.25738. Epub 2019 Mar 19. No abstract available.

PMID:
30990235
11.

Limited stage grade 3 follicular lymphoma patients can experience favorable outcomes with combined modality therapy.

Ayoub Z, Andraos T, Milgrom SA, Pinnix CC, Dabaja BS, Ng SP, Gunther JR, Khoury JD, Fowler NH, Neelapu SS, Samaniego F, Fayad LE, Nastoupil LJ.

Leuk Lymphoma. 2019 Apr 3:1-9. doi: 10.1080/10428194.2019.1597081. [Epub ahead of print]

PMID:
30942648
12.

Early Stage Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes.

Andraos T, Ayoub Z, Nastoupil L, Pinnix C, Milgrom S, Gunther J, Ng SP, Fowler N, Neelapu S, Samaniego F, Dabaja B.

Clin Lymphoma Myeloma Leuk. 2019 Jun;19(6):381-389. doi: 10.1016/j.clml.2019.02.011. Epub 2019 Feb 26.

PMID:
30935940
13.

Lenalidomide plus rituximab (R2 ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trial.

Becnel MR, Nastoupil LJ, Samaniego F, Davis RE, You MJ, Green M, Hagemeister FB, Fanale MA, Fayad LE, Westin JR, Wang M, Oki Y, Forbes SG, Feng L, Neelapu SS, Fowler NH.

Br J Haematol. 2019 Jun;185(5):874-882. doi: 10.1111/bjh.15843. Epub 2019 Mar 28.

14.

AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma.

Leonard JP, Trneny M, Izutsu K, Fowler NH, Hong X, Zhu J, Zhang H, Offner F, Scheliga A, Nowakowski GS, Pinto A, Re F, Fogliatto LM, Scheinberg P, Flinn IW, Moreira C, Cabeçadas J, Liu D, Kalambakas S, Fustier P, Wu C, Gribben JG; AUGMENT Trial Investigators.

J Clin Oncol. 2019 May 10;37(14):1188-1199. doi: 10.1200/JCO.19.00010. Epub 2019 Mar 21.

PMID:
30897038
15.

Primary central nervous system lymphoma in patients with and without HIV infection: a multicenter study and comparison with U.S national data.

Dandachi D, Ostrom QT, Chong I, Serpa JA, Giordano TP, Kruchko C, Barnholtz-Sloan JS, Fowler N, Colen RR, Morón FE.

Cancer Causes Control. 2019 May;30(5):477-488. doi: 10.1007/s10552-019-01144-8. Epub 2019 Mar 19.

PMID:
30888569
16.

Stress as a potential moderator of ovarian hormone influences on binge eating in women.

Fowler N, Vo PT, Sisk CL, Klump KL.

F1000Res. 2019 Feb 27;8. pii: F1000 Faculty Rev-222. doi: 10.12688/f1000research.16895.1. eCollection 2019. Review.

17.

Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphoma.

Strati P, Lee ST, Teegavarupu P, Karri A, Anireddy S, Hagemeister FB, Romaguera J, Fayad LE, Rodriguez MA, Samaniego F, Fowler N, Westin J, Wang M, Lee HJ, Pinnix C, Gunther JR, Dabaja B, Feng L, Davis RE, Neelapu SS.

Am J Hematol. 2019 Jun;94(6):E150-E153. doi: 10.1002/ajh.25447. Epub 2019 Mar 6. No abstract available.

PMID:
30785215
18.

Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.

Pinnix CC, Gunther JR, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, Amini B, Neelapu S, Lee HJ, Westin J, Fowler N, Nastoupil L, Dabaja B.

Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):447-455. doi: 10.1016/j.ijrobp.2019.02.002. Epub 2019 Feb 12.

PMID:
30769175
19.

Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma.

Saini NY, Saliba RM, Rondon G, Maadani F, Popat U, Hosing CM, Oran B, Bashir Q, Olson A, Nieto Y, Alousi A, Kebriaei P, Srour S, Mehta R, Anderlini P, Shpall EJ, Qazilbash MH, Khouri IF, Fayad L, Lee H, Fowler N, Parmar S, Westin J, Hagemeister F, Champlin RE, Ciurea SO.

Biol Blood Marrow Transplant. 2019 Jul;25(7):1340-1346. doi: 10.1016/j.bbmt.2019.02.002. Epub 2019 Feb 11.

PMID:
30763728
20.

Tolerability and activity of ublituximab, umbralisib, and ibrutinib in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: a phase 1 dose escalation and expansion trial.

Nastoupil LJ, Lunning MA, Vose JM, Schreeder MT, Siddiqi T, Flowers CR, Cohen JB, Burger JA, Wierda WG, O'Brien S, Sportelli P, Miskin HP, Purdom MA, Weiss MS, Fowler NH.

Lancet Haematol. 2019 Feb;6(2):e100-e109. doi: 10.1016/S2352-3026(18)30216-3.

PMID:
30709431
21.

Post-radiotherapy PET/CT for predicting treatment outcomes in head and neck cancer after postoperative radiotherapy.

Li Y, Awan MJ, Chang T, Lavertu P, Zender C, Rezaee R, Fowler N, Wasman J, Avril NE, Chen N, Machtay M, Yao M.

Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):794-800. doi: 10.1007/s00259-019-4272-8. Epub 2019 Jan 24.

PMID:
30680587
22.

Associations between ovarian hormones and emotional eating across the menstrual cycle: Do ovulatory shifts in hormones matter?

Fowler N, Keel PK, Burt SA, Neale M, Boker S, Sisk CL, Klump KL.

Int J Eat Disord. 2019 Feb;52(2):195-199. doi: 10.1002/eat.22985. Epub 2019 Jan 15.

PMID:
30648266
23.

Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?

Chihara D, Oki Y, Fanale MA, Westin JR, Nastoupil LJ, Neelapu S, Fayad L, Fowler NH, Cheah CY.

Ann Hematol. 2019 May;98(5):1169-1176. doi: 10.1007/s00277-018-3571-7. Epub 2019 Jan 8.

PMID:
30617643
24.

Eye Gaze Markers Indicate Visual Attention to Threatening Images in Individuals with Chronic Back Pain.

Franklin ZC, Holmes PS, Fowler NE.

J Clin Med. 2018 Dec 31;8(1). pii: E31. doi: 10.3390/jcm8010031.

25.

Supporting breast cancer screening decisions for caregivers of older women with dementia: study protocol for a randomized controlled trial.

Fowler NR, Schonberg MA, Sachs GA, Schwartz PH, Gao S, Lane KA, Inger L, Torke AM.

Trials. 2018 Dec 12;19(1):678. doi: 10.1186/s13063-018-3039-z.

26.

STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial.

Reilley MJ, McCoon P, Cook C, Lyne P, Kurzrock R, Kim Y, Woessner R, Younes A, Nemunaitis J, Fowler N, Curran M, Liu Q, Zhou T, Schmidt J, Jo M, Lee SJ, Yamashita M, Hughes SG, Fayad L, Piha-Paul S, Nadella MVP, Xiao X, Hsu J, Revenko A, Monia BP, MacLeod AR, Hong DS.

J Immunother Cancer. 2018 Nov 16;6(1):119. doi: 10.1186/s40425-018-0436-5.

27.

Les temps changent-ils vraiment?

Rainsberry P, Nasmith L, Weston WW, Busing N, Fowler N, Goertzen J, Kvern B, Tannenbaum D, Oandasan IF.

Can Fam Physician. 2018 Nov;64(11):e473-e476. French. No abstract available.

PMID:
30429190
Free PMC Article
28.

Linking education and practice: The Outcomes of Training project.

Lemire F, Fowler N.

Can Fam Physician. 2018 Nov;64(11):866. No abstract available.

29.

Relier l’éducation à la pratique: Le projet sur les finalités d’apprentissage.

Lemire F, Fowler N.

Can Fam Physician. 2018 Nov;64(11):865. French. No abstract available.

PMID:
30429187
Free PMC Article
30.

The times, are they a-changin'?

Rainsberry P, Nasmith L, Weston WW, Busing N, Fowler N, Goertzen J, Kvern B, Tannenbaum D, Oandasan IF.

Can Fam Physician. 2018 Nov;64(11):798-800. No abstract available.

31.

Does Substrate Positioning Affect the Selectivity and Reactivity in the Hectochlorin Biosynthesis Halogenase?

Timmins A, Fowler NJ, Warwicker J, Straganz GD, de Visser SP.

Front Chem. 2018 Oct 30;6:513. doi: 10.3389/fchem.2018.00513. eCollection 2018.

32.

Health information management practices in informal caregiving: An artifacts analysis and implications for IT design.

Holden RJ, Karanam YLP, Cavalcanti LH, Parmar T, Kodthala P, Fowler NR, Bateman DR.

Int J Med Inform. 2018 Dec;120:31-41. doi: 10.1016/j.ijmedinf.2018.09.017. Epub 2018 Sep 17.

PMID:
30409344
33.

Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy.

Sheu T, Milgrom SA, Andraos TY, Gunther JR, Chi L, Nastoupil L, Fowler N, Oki Y, Fanale MA, Fayad LE, Hagemeister F, Neelapu SS, Medeiros LJ, Hosing C, Nieto Y, Ahmed S, Alousi AM, Dabaja B, Pinnix CC.

Adv Radiat Oncol. 2018 Jul 12;3(4):639-646. doi: 10.1016/j.adro.2018.07.001. eCollection 2018 Oct-Dec.

34.

Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy.

Yoder AK, Gunther JR, Milgrom SA, Mirkovic D, Nastoupil L, Neelapu S, Fanale M, Fowler N, Westin J, Lee HJ, Rodriguez MA, Iyer SP, Fayad L, Nieto YL, Hosing C, Ahmed S, Medeiros LJ, Khoury JD, Garg N, Amini B, Dabaja BS, Pinnix CC.

Clin Lymphoma Myeloma Leuk. 2019 Jan;19(1):e51-e61. doi: 10.1016/j.clml.2018.09.002. Epub 2018 Sep 10.

PMID:
30360985
35.

Response to pembrolizumab and lenalidomide in advanced refractory mycosis fungoides.

Fountain E, Mistry H, Jain P, Duvic M, Fowler N.

Leuk Lymphoma. 2019 Apr;60(4):1079-1082. doi: 10.1080/10428194.2018.1516879. Epub 2018 Oct 10. No abstract available.

PMID:
30301395
36.

Correction: Analytical Sensitivity Comparison between Singleplex Real-Time PCR and a Multiplex PCR Platform for Detecting Respiratory Viruses.

Parker J, Fowler N, Walmsley ML, Schmidt T, Scharrer J, Kowaleski J, Grimes T, Hoyos S, Chen J.

PLoS One. 2018 Oct 4;13(10):e0205483. doi: 10.1371/journal.pone.0205483. eCollection 2018.

37.

Patient characteristics associated with screening positive for Alzheimer's disease and related dementia.

Fowler NR, Perkins AJ, Gao S, Sachs GA, Uebelhor AK, Boustani MA.

Clin Interv Aging. 2018 Sep 17;13:1779-1785. doi: 10.2147/CIA.S164957. eCollection 2018.

38.

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.

Morschhauser F, Fowler NH, Feugier P, Bouabdallah R, Tilly H, Palomba ML, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Daguindau N, Le Gouill S, Pica GM, Martin Garcia-Sancho A, López-Guillermo A, Larouche JF, Ando K, Gomes da Silva M, André M, Zachée P, Sehn LH, Tobinai K, Cartron G, Liu D, Wang J, Xerri L, Salles GA; RELEVANCE Trial Investigators.

N Engl J Med. 2018 Sep 6;379(10):934-947. doi: 10.1056/NEJMoa1805104.

39.

Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib.

Jain P, Kanagal-Shamanna R, Zhang S, Ahmed M, Ghorab A, Zhang L, Ok CY, Li S, Hagemeister F, Zeng D, Gong T, Chen W, Badillo M, Nomie K, Fayad L, Medeiros LJ, Neelapu S, Fowler N, Romaguera J, Champlin R, Wang L, Wang ML.

Br J Haematol. 2018 Nov;183(4):578-587. doi: 10.1111/bjh.15567. Epub 2018 Sep 2.

PMID:
30175400
40.

Prevalence of a Histologic Change of Ocular Adnexal Lymphoma in Patients With a History of Lymphoma.

Sagiv O, Thakar SD, Manning JT, Kandl TJ, Fayad LE, Fowler N, Hagemeister FB, Fanale MA, Pinnix CC, Samaniego F, Esmaeli B.

Ophthalmic Plast Reconstr Surg. 2018 Aug 17. doi: 10.1097/IOP.0000000000001215. [Epub ahead of print]

PMID:
30124609
41.

Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study.

de Vos S, Swinnen LJ, Wang D, Reid E, Fowler N, Cordero J, Dunbar M, Enschede SH, Nolan C, Petrich AM, Ross JA, Salem AH, Verdugo M, Agarwal S, Zhou L, Kozloff M, Nastoupil LJ, Flowers CR.

Ann Oncol. 2018 Sep 1;29(9):1932-1938. doi: 10.1093/annonc/mdy256.

42.

Improving Nursing Facility Care Through an Innovative Payment Demonstration Project: Optimizing Patient Transfers, Impacting Medical Quality, and Improving Symptoms: Transforming Institutional Care Phase 2.

Unroe KT, Fowler NR, Carnahan JL, Holtz LR, Hickman SE, Effler S, Evans R, Frank KI, Ott ML, Sachs G.

J Am Geriatr Soc. 2018 Aug;66(8):1625-1631. doi: 10.1111/jgs.15462. Epub 2018 Jul 18.

PMID:
30019762
43.

Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis.

Chihara D, Fowler NH, Oki Y, Fanale MA, Nastoupil LJ, Westin JR, Fayad LE, Neelapu SS, Cheah CY.

Oncotarget. 2018 Jun 22;9(48):28897-28902. doi: 10.18632/oncotarget.25622. eCollection 2018 Jun 22.

44.

Stage I Non-Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement.

Chihara D, Oki Y, Fanale MA, Westin JR, Nastoupil LJ, Neelapu S, Fayad L, Fowler NH, Cheah CY.

Br J Haematol. 2019 Apr;185(2):334-338. doi: 10.1111/bjh.15444. Epub 2018 Jul 5. No abstract available.

PMID:
29978452
45.

Estrogen moderates genetic influences on binge eating during puberty: Disruption of normative processes?

Klump KL, Fowler N, Mayhall L, Sisk CL, Culbert KM, Burt SA.

J Abnorm Psychol. 2018 Jul;127(5):458-470. doi: 10.1037/abn0000352. Epub 2018 Jun 21.

46.

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.

Gopal AK, Schuster SJ, Fowler NH, Trotman J, Hess G, Hou JZ, Yacoub A, Lill M, Martin P, Vitolo U, Spencer A, Radford J, Jurczak W, Morton J, Caballero D, Deshpande S, Gartenberg GJ, Wang SS, Damle RN, Schaffer M, Balasubramanian S, Vermeulen J, Cheson BD, Salles G.

J Clin Oncol. 2018 Aug 10;36(23):2405-2412. doi: 10.1200/JCO.2017.76.8853. Epub 2018 May 31.

PMID:
29851546
47.

Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.

Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, Ju Lee H, Oki Y, Wang M, Samaniego F, Chi L, Esmaeli B.

Head Neck. 2018 Jun;40(6):1335. doi: 10.1002/hed.25149. Epub 2018 Feb 21. No abstract available.

PMID:
29851218
48.

Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL).

Jain P, Romaguera J, Srour SA, Lee HJ, Hagemeister F, Westin J, Fayad L, Samaniego F, Badillo M, Zhang L, Nastoupil L, Kanagal-Shamanna R, Fowler N, Wang ML.

Br J Haematol. 2018 Aug;182(3):404-411. doi: 10.1111/bjh.15411. Epub 2018 May 22.

PMID:
29785709
49.

Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma.

Romaguera JE, Wang M, Feng L, Fayad LE, Hagemeister F, McLaughlin P, Rodriguez MA, Fanale M, Orlowski R, Kwak LW, Neelapu S, Oki Y, Pro B, Younes A, Samaniego F, Fowler N, Hartig K, Valentinetti M, Smith J, Ford P, Naig A, Medeiros LJ, Kantarjian HM, Goy A.

Cancer. 2018 Jun 15;124(12):2561-2569. doi: 10.1002/cncr.31361. Epub 2018 May 3.

50.

Assessing patient risk of central line-associated bacteremia via machine learning.

Beeler C, Dbeibo L, Kelley K, Thatcher L, Webb D, Bah A, Monahan P, Fowler NR, Nicol S, Judy-Malcolm A, Azar J.

Am J Infect Control. 2018 Sep;46(9):986-991. doi: 10.1016/j.ajic.2018.02.021. Epub 2018 Apr 13.

PMID:
29661634

Supplemental Content

Loading ...
Support Center